nodes	percent_of_prediction	percent_of_DWPC	metapath
Phensuximide—CACNA1G—Nicotine Activity on Chromaffin Cells—CACNA1C—attention deficit hyperactivity disorder	0.199	0.271	CbGpPWpGaD
Phensuximide—CACNA1I—NCAM1 interactions—CACNB2—attention deficit hyperactivity disorder	0.052	0.0709	CbGpPWpGaD
Phensuximide—CACNA1I—NCAM1 interactions—CACNA1C—attention deficit hyperactivity disorder	0.0476	0.0649	CbGpPWpGaD
Phensuximide—CACNA1G—NCAM1 interactions—CACNB2—attention deficit hyperactivity disorder	0.0383	0.0523	CbGpPWpGaD
Phensuximide—CACNA1H—NCAM1 interactions—CACNB2—attention deficit hyperactivity disorder	0.0371	0.0506	CbGpPWpGaD
Phensuximide—CACNA1G—NCAM1 interactions—CACNA1C—attention deficit hyperactivity disorder	0.0351	0.0478	CbGpPWpGaD
Phensuximide—CACNA1H—NCAM1 interactions—CACNA1C—attention deficit hyperactivity disorder	0.034	0.0463	CbGpPWpGaD
Phensuximide—CACNA1I—NCAM signaling for neurite out-growth—CACNB2—attention deficit hyperactivity disorder	0.0306	0.0417	CbGpPWpGaD
Phensuximide—CACNA1I—cerebellum—attention deficit hyperactivity disorder	0.0296	0.154	CbGeAlD
Phensuximide—CACNA1I—NCAM signaling for neurite out-growth—CACNA1C—attention deficit hyperactivity disorder	0.028	0.0381	CbGpPWpGaD
Phensuximide—CACNA1I—brain—attention deficit hyperactivity disorder	0.0241	0.125	CbGeAlD
Phensuximide—CACNA1G—NCAM signaling for neurite out-growth—CACNB2—attention deficit hyperactivity disorder	0.0225	0.0307	CbGpPWpGaD
Phensuximide—CACNA1H—cardiovascular system—attention deficit hyperactivity disorder	0.022	0.114	CbGeAlD
Phensuximide—CACNA1H—NCAM signaling for neurite out-growth—CACNB2—attention deficit hyperactivity disorder	0.0218	0.0298	CbGpPWpGaD
Phensuximide—CACNA1G—nervous system—attention deficit hyperactivity disorder	0.0216	0.112	CbGeAlD
Phensuximide—CACNA1G—central nervous system—attention deficit hyperactivity disorder	0.0208	0.108	CbGeAlD
Phensuximide—CACNA1G—NCAM signaling for neurite out-growth—CACNA1C—attention deficit hyperactivity disorder	0.0206	0.0281	CbGpPWpGaD
Phensuximide—CACNA1G—cerebellum—attention deficit hyperactivity disorder	0.0203	0.105	CbGeAlD
Phensuximide—CACNA1H—NCAM signaling for neurite out-growth—CACNA1C—attention deficit hyperactivity disorder	0.02	0.0272	CbGpPWpGaD
Phensuximide—Phenmetrazine—SLC6A3—attention deficit hyperactivity disorder	0.0193	0.263	CrCbGaD
Phensuximide—CACNA1G—brain—attention deficit hyperactivity disorder	0.0165	0.0855	CbGeAlD
Phensuximide—Phendimetrazine—SLC6A3—attention deficit hyperactivity disorder	0.016	0.218	CrCbGaD
Phensuximide—CACNA1H—nervous system—attention deficit hyperactivity disorder	0.0141	0.0731	CbGeAlD
Phensuximide—CACNA1H—cerebellum—attention deficit hyperactivity disorder	0.0133	0.0688	CbGeAlD
Phensuximide—CACNA1I—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.0124	0.017	CbGpPWpGaD
Phensuximide—CACNA1H—brain—attention deficit hyperactivity disorder	0.0108	0.0559	CbGeAlD
Phensuximide—Primidone—CHRNA4—attention deficit hyperactivity disorder	0.0101	0.138	CrCbGaD
Phensuximide—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00997	0.135	CrCbGaD
Phensuximide—Methylphenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.00951	0.129	CrCbGaD
Phensuximide—CACNA1G—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00918	0.0125	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00889	0.0121	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00888	0.0121	CbGpPWpGaD
Phensuximide—CACNA1I—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00877	0.012	CbGpPWpGaD
Phensuximide—Tranylcypromine—MAOA—attention deficit hyperactivity disorder	0.00865	0.118	CrCbGaD
Phensuximide—CACNA1I—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00802	0.0109	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00655	0.00893	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00646	0.00881	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00634	0.00865	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00626	0.00854	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00626	0.00853	CbGpPWpGaD
Phensuximide—CACNA1G—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00591	0.00806	CbGpPWpGaD
Phensuximide—CACNA1H—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00573	0.00781	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00572	0.0078	CbGpPWpGaD
Phensuximide—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00538	0.00733	CbGpPWpGaD
Phensuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00514	0.00701	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00461	0.00629	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00447	0.00609	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00422	0.00575	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00409	0.00557	CbGpPWpGaD
Phensuximide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00244	0.00332	CbGpPWpGaD
Phensuximide—CACNA1I—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00163	0.00222	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0013	0.00178	CbGpPWpGaD
Phensuximide—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00129	0.00177	CbGpPWpGaD
Phensuximide—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00129	0.00175	CbGpPWpGaD
Phensuximide—CACNA1G—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.0012	0.00163	CbGpPWpGaD
Phensuximide—CACNA1H—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00116	0.00158	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000533	0.000727	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000368	0.000502	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000368	0.000502	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000362	0.000494	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000337	0.000459	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000294	0.000401	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00028	0.000382	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000223	0.000304	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000221	0.000302	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000215	0.000293	CbGpPWpGaD
Phensuximide—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	9.56e-05	0.00013	CbGpPWpGaD
